Lataa...
Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1‐G93A mouse model
AIMS: To investigate the effect and mechanisms of carbamazepine (CBZ) on the onset and progression of amyotrophic lateral sclerosis (ALS) in SOD1‐G93A mouse model. METHODS: Starting from 64 days of age, SOD1‐G93A mice were orally administered with CBZ at 200 mg/kg once daily until death. The disease...
Tallennettuna:
| Julkaisussa: | CNS Neurosci Ther |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489874/ https://ncbi.nlm.nih.gov/pubmed/29656576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12855 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|